- Home
- AHG vs SOPH Comparison
AHG vs SOPH Comparison
Compare AHG & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHG
- SOPH
- Stock Information
- Founded
- AHG 2013
- SOPH 2011
- Country
- AHG China
- SOPH Switzerland
- Employees
- AHG N/A
- SOPH N/A
- Industry
- AHG Business Services
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AHG Consumer Discretionary
- SOPH Health Care
- Exchange
- AHG Nasdaq
- SOPH Nasdaq
- Market Cap
- AHG 446.7M
- SOPH 226.6M
- IPO Year
- AHG N/A
- SOPH 2021
- Fundamental
- Price
- AHG $1.69
- SOPH $3.24
- Analyst Decision
- AHG
- SOPH Strong Buy
- Analyst Count
- AHG 0
- SOPH 3
- Target Price
- AHG N/A
- SOPH $7.00
- AVG Volume (30 Days)
- AHG 369.0K
- SOPH 24.0K
- Earning Date
- AHG 01-10-2025
- SOPH 11-05-2024
- Dividend Yield
- AHG N/A
- SOPH N/A
- EPS Growth
- AHG N/A
- SOPH N/A
- EPS
- AHG N/A
- SOPH N/A
- Revenue
- AHG $2,414,338.00
- SOPH $64,488,000.00
- Revenue This Year
- AHG N/A
- SOPH $7.20
- Revenue Next Year
- AHG N/A
- SOPH $15.71
- P/E Ratio
- AHG N/A
- SOPH N/A
- Revenue Growth
- AHG N/A
- SOPH 9.85
- 52 Week Low
- AHG $0.60
- SOPH $2.70
- 52 Week High
- AHG $2.90
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- AHG 57.65
- SOPH 45.15
- Support Level
- AHG $1.11
- SOPH $3.00
- Resistance Level
- AHG $1.40
- SOPH $3.38
- Average True Range (ATR)
- AHG 0.28
- SOPH 0.19
- MACD
- AHG 0.01
- SOPH 0.00
- Stochastic Oscillator
- AHG 51.47
- SOPH 36.00
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.